Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EIX vs GSK✓SelectedUSD · GSKEIX vs GSK performance historyLatest closeAs of-1.24%11/20
Stock and ETF performance explorer

EIX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+38.6%
GSK return
+97.4%
Excess return
-58.8%
Maximum drawdown
-43.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.2%-0.1%-1.1%-1.2%
7D+3.4%-5.3%+8.8%+5.5%
30D+8.8%-3.7%+12.5%+10.2%
3M-15.3%-7.3%-8.0%-13.1%
6M-8.2%-4.2%-4.0%-7.2%
YTD+9.5%+0.9%+8.7%+7.9%
1Y+13.2%+7.3%+5.9%+8.8%
3Y+10.5%+52.7%-42.2%-10.9%
5Y+22.0%+40.1%-18.1%-0.1%
All+38.6%+97.4%-58.8%-4.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling